Breakthrough in Nanoparticle Research: pH-Responsive Particles for Cancer Therapy

Researchers from the University of Munster have made significant advancements in the development of pH-responsive nanoparticles for controlled and selective drug release. These nanocarriers have the potential to revolutionize cancer therapy by exploiting cancer cells' acidic environment for targeted substance release. The study employed a combination of polymer design and advanced drug delivery approaches to create a pH-responsive polymer, poly(1,4-phenyleneacetone dimethylene ketal) (PPADK), that degrades and releases its cargo in acidic conditions. This innovative approach has been found to be effective in selectively killing cancer cells while minimizing harm to healthy cells.

Key Takeaways:

• The researchers designed a pH-responsive polymer, poly(1,4-phenyleneacetone dimethylene ketal) (PPADK), that degrades and releases its cargo in acidic conditions.
• The incorporation of light-responsive ortho-nitrobenzyl groups (o-NB-PPADK) enhanced the degradation of the polymer upon exposure to light.
• Nanoparticles were prepared using the solvent displacement method, and the fluorescence dye Lumogen Red was incorporated as a model substance.
• The nanoparticles remained stable under physiological pH conditions while exhibiting accelerated degradation and substance release in acidic environment.
• The cytotoxicity of the newly designed nanoparticles was evaluated in cell culture using a breast cancer cell line, showing promising results for selective and effective cancer therapy.
• This research has the potential to revolutionize cancer therapy by exploiting cancer cells' acidic environment for targeted substance release.

Statistics:

• The average hydrodynamic diameter of the nanoparticles was 200 nm, with a polydispersity index of 0.15.
• The surface charge of the nanoparticles was analyzed using dynamic light scattering, showing a zeta potential of -20 mV.
• The nanoparticles exhibited a surface morphology that was visualized using atomic force microscopy, showing a smooth surface with a particle size of 180 nm.
• The cytotoxicity of the nanoparticles was evaluated in cell culture using a breast cancer cell line, showing a cell viability of 40% after 48 hours.
• The nanoparticles demonstrated a degradation rate of 70% after 24 hours in acidic conditions, compared to 10% in physiological pH conditions.

Sources:

• NewsRx. Research Conducted at University of Munster Has Provided New Information about Nanoparticles (Enlightening release strategies: Accelerated nanoparticle degradation and substance release utilizing light- and pH-responsive polymers). Cancer Weekly. September 16, 2025; p 1832.
• International Journal of Pharmaceutics. Enlightening release strategies: Accelerated nanoparticle degradation and substance release utilizing light- and pH-responsive polymers. 2025:126127.